Compare ADMA Biologics Inc (ADMA) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs iShares 1 3 Year Treasury Bond ETF — how do they compare? ADMA Biologics Inc trades at $9.85 (market cap $2.22B), while iShares 1 3 Year Treasury Bond ETF trades at $81.96. Which is the better fit depends on your goals.
| ADMA | SHY | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Fixed Income |
52-Week High | $20.38 | $83.18 |
52-Week Low | $7.60 | $81.77 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
